SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-22-007913
Filing Date
2022-07-22
Accepted
2022-07-22 16:27:29
Documents
1
Period of Report
2022-07-12

Document Format Files

Seq Description Document Type Size
1 form3-07222022_010718.html 3  
1 form3-07222022_010718.xml 3 2805
  Complete submission text file 0001415889-22-007913.txt   4280
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address
Willard Stephen H (Reporting) CIK: 0001325232 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38302 | Film No.: 221100196

Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Issuer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations